Biomarkers in Neurodegenerative Disease Trials
Biomarkers in Neurodegenerative Disease Trials Integrating Biomarkers into Neurodegenerative Disease Clinical Trials The Growing Role of Biomarkers in CNS Trials Neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease, and amyotrophic lateral sclerosis (ALS) pose significant challenges for diagnosis, monitoring, and therapeutic evaluation. Biomarkers are increasingly essential in these areas, enabling early…
Read More “Biomarkers in Neurodegenerative Disease Trials” »